Antibacterial and antiviral potential of harmalacidine hydrochloride, a β-carboline alkaloid, against respiratory tract pathogens: Staphylococcus aureus and H1N1 influenza virus

TL;DR

This study shows that harmalacidine hydrochloride has antibacterial and antiviral effects against Staphylococcus aureus and H1N1 influenza virus, making it a potential treatment for respiratory infections.

Contribution

The study identifies harmalacidine hydrochloride as a promising compound with dual antibacterial and antiviral activity against key respiratory pathogens.

Findings

Harmalacidine hydrochloride showed antiviral activity against H1N1 with an IC50 of 68.2 ± 0.8 µg/mL.

The compound exhibited antibacterial activity with MICs ranging from 16 to 128 µg/mL.

Molecular docking suggests harmalacidine hydrochloride binds to S. aureus AgrA and H1N1 viral proteins.

Abstract

Respiratory infections remain a leading cause of morbidity and mortality, necessitating new therapeutic strategies. This study evaluated the antiviral and antibacterial activities of harmine, harmaline, and harmalacidine hydrochloride against H1N1 influenza virus and Staphylococcus aureus, key respiratory pathogens. The in vitro antiviral activity of the tested compounds against the H1N1 virus was evaluated using a plaque assay. Harmalacidine hydrochloride demonstrated notable activity, with an IC50 of 68.2 ± 0.8 µg/mL, while harmine and harmaline showed no significant effects at non-cytotoxic concentrations. The potential antibacterial action of the tested compounds was initially investigated by agar well diffusion method, which revealed clear zones of inhibition around the wells. Subsequently, their minimum inhibitory concentrations (MICs) were recorded using the broth microdilution method. Harmalacidine hydrochloride exhibited the highest antibacterial action with MICs from 16 to 128 µg/mL. Based on these findings, further investigations were conducted to assess the effect of harmalacidine hydrochloride on membrane integrity and permeability, cellular morphology, and biofilm formation. A noticeable reduction (p < 0.05) in the membrane integrity and a distinct escalation (p < 0.05) in the permeability were noticed in 46.15% and 53.85% of the tested isolates, respectively. Moreover, scanning electron microscopy revealed pronounced distortion in cellular morphology following harmalacidine hydrochloride treatment. The compound also exhibited antibiofilm activity, as demonstrated by the crystal violet assay, alongside a downregulation of biofilm-associated gene expression. Molecular docking revealed that harmalacidinium ion binds strongly to the Accessory Gene Regulator A (AgrA) of S. aureus, suggesting antibacterial activity through inhibition of quorum sensing-mediated virulence. It also showed high affinity for H1N1 neuraminidase and polymerase basic protein 2 (PB2), indicating potential antiviral activity. However, experimental enzyme assays and in vivo studies are required to confirm the proposed antiviral and antibacterial mechanisms.

Figures